Drugs / MenACWY-PS Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00262028 Comparator | Apr 2005 → Nov 2006 | meningococcemia | Novartis Vaccines | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MenACWY-PS Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00262028 ↗ |
| Modality | Vaccine | “MenACWY-PS Vaccine” NCT00262028 ↗ |